CoreCap Advisors’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.48K Hold
411
﹤0.01% 2382
2026
Q1
$2.24K Hold
411
﹤0.01% 2383
2025
Q4
$2.88K Hold
411
﹤0.01% 2372
2025
Q3
$3.18K Sell
411
-1,300
-76% -$10.1K ﹤0.01% 2285
2025
Q2
$14.9K Sell
1,711
-125
-7% -$906 ﹤0.01% 1711
2025
Q1
$14.6K Sell
1,836
-300
-14% -$3.04K ﹤0.01% 1665
2024
Q4
$19.4K Buy
2,136
+51
+2% +$492 ﹤0.01% 1549
2024
Q3
$19.1K Hold
2,085
﹤0.01% 1582
2024
Q2
$20.4K Sell
2,085
-800
-28% -$9.76K ﹤0.01% 892
2024
Q1
$43.6K Buy
+2,885
New +$52.4K ﹤0.01% 1172
2022
Q4
$1.51K Buy
+64
New +$1.73K ﹤0.01% 1990
2022
Q3
Sell
-529
Closed -$18K 1913
2022
Q2
$18K Buy
+529
New +$22.5K ﹤0.01% 1289
2022
Q1
Sell
-103
Closed -$9K 1916
2021
Q4
$9K Buy
+103
New +$12.3K ﹤0.01% 1598

Other funds holding TDOC

CoreCap Advisors's TDOC Position: Q2 2026 in Review

CoreCap Advisors held its Teladoc Health (TDOC) position steady in Q2 2026 at 411 shares worth $3.48K. The position accounts for ﹤0.01% of the portfolio, ranked #2382.

CoreCap Advisors first reported a position in TDOC in Q4 2021 and has held it in 13 quarters since. The position peaked at $43.6K in Q1 2024. 348 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • CoreCap Advisors held 411 shares of Teladoc Health worth $3.48K as of Q2 2026.
  • CoreCap Advisors left its Teladoc Health share count unchanged in Q2 2026.
  • Teladoc Health made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #2382 holding.
  • CoreCap Advisors first reported a position in Teladoc Health in Q4 2021 and has held it in 13 quarters since.
  • CoreCap Advisors's Teladoc Health position peaked at $43.6K in Q1 2024.
  • 348 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.